Literature DB >> 21375422

Ex vivo expansion of natural killer cells: a question of function.

Tolga Sutlu, Evren Alici.   

Abstract

Mesh：

Year:  2011        PMID： 21375422     DOI： 10.3109/14653249.2011.563295

Source DB:  PubMed          Journal:  Cytotherapy        ISSN： 1465-3249            Impact factor:   5.414


× No keyword cloud information.
  8 in total

Review 1.  Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.

Authors:  Martha Luevano; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

2. 

Authors:  茜璇 卢; 黎莎 包; 宗富 潘; 明华 葛
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

Review 3.  Immunotherapy for anaplastic thyroid carcinoma: the present and future.

Authors:  Xixuan Lu; Lisha Bao; Zongfu Pan; Minghua Ge
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

4.  Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells.

Authors:  Cecele J Denman; Vladimir V Senyukov; Srinivas S Somanchi; Prasad V Phatarpekar; Lisa M Kopp; Jennifer L Johnson; Harjeet Singh; Lenka Hurton; Sourindra N Maiti; M Helen Huls; Richard E Champlin; Laurence J N Cooper; Dean A Lee
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

Review 5.  Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation.

Authors:  Markus Granzin; Juliane Wagner; Ulrike Köhl; Adelheid Cerwenka; Volker Huppert; Evelyn Ullrich
Journal:  Front Immunol       Date:  2017-04-26       Impact factor: 7.561

6.  Manufacturing NKG2D CAR-T cells with piggyBac transposon vectors and K562 artificial antigen-presenting cells.

Authors:  Johan C K Tay; Junjian Wang; Zhicheng Du; Yu Yang Ng; Zhendong Li; Yuefang Ren; Chang Zhang; Jianqing Zhu; Xue Hu Xu; Shu Wang
Journal:  Mol Ther Methods Clin Dev       Date:  2021-03-03       Impact factor: 6.698

7.  Advances in clinical NK cell studies: Donor selection, manufacturing and quality control.

Authors:  U Koehl; C Kalberer; J Spanholtz; D A Lee; J S Miller; S Cooley; M Lowdell; L Uharek; H Klingemann; A Curti; W Leung; E Alici
Journal:  Oncoimmunology       Date:  2015-11-11       Impact factor: 8.110

Review 8.  Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.

Authors:  Carin I M Dahlberg; Dhifaf Sarhan; Michael Chrobok; Adil D Duru; Evren Alici
Journal:  Front Immunol       Date:  2015-11-30       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.